Schedule 13G ownership disclosure

LIMINATUS PHARMA INC.

Common Stock, $0.0001 par value per share · CUSIP: 53271X108

Event date: 2025-04-30

Filing-level shares
4,000,000
Percent of class
15.4%
  • KH Feelux Co., Ltd

    Shares: 4,000,000 · Class: 15.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-091130
Form type
SCHEDULE 13G
Filer
KH Feelux Co., Ltd
CIK
CIK 2068957
Filed
Jun 27, 2025
Reporting period
Apr 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub